Long-chain non-coding RNA marker for early diagnosis of malignant melanoma and application thereof
A malignant melanoma, long-chain non-coding technology, applied in the field of molecular diagnosis, can solve problems such as lack of new research, and achieve the effect of high sensitivity and specificity, high diagnostic characteristics, high clinical application potential and promotion effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Embodiment 1qRT-PCR verifies the expression of Linc01296 in serum
[0038] 1. Experimental materials
[0039] 1. Serum collected from 98 healthy controls, skin benign moles, and malignant melanoma patients.
[0040] 2. Dye-based Linc01296 qRT-PCR kit, the components are as follows:
[0041] (1) Linc01296 upstream primer (sequence such as SEQ ID NO.2)
[0042] (2) Linc01296 downstream primer (sequence such as SEQ ID NO.3)
[0043] (3) U6 upstream primer (internal reference calibration gene, sequence such as SEQ ID NO.4)
[0044] (4) U6 downstream primer (internal reference calibration gene, sequence such as SEQ ID NO.5)
[0045] (5) 2×one-step reverse transcription-fluorescent quantitative PCR mixture
[0046] (6) Hot start Taq enzyme
[0047] (7) RTase reverse transcriptase
[0048] (8) DEPC-ddH 2 o
[0049] 2. Experimental method
[0050] 1. Total RNA Extraction from Serum Samples
[0051] The total RNA in the serum of healthy controls, skin benign moles and...
Embodiment 2
[0085] Example 2 ROC curve analysis of the diagnostic value of serum Linc01296 expression in malignant melanoma
[0086] On the basis of detecting the relative expression levels of Linc01296 in the serum of malignant melanoma patients and healthy controls, the ROC curve was drawn using SPSS 22.0 software for the qRT-PCR reaction results. The result is as image 3 It shows that the area under the ROC curve of serum Linc01296 for the diagnosis of malignant melanoma is 0.896 (95% CI: 0.847-0.946; P<0.001), the optimal diagnostic threshold of serum Linc01296 for colorectal cancer is 2.149, and the sensitivity is 84.69%. The specificity was 88.77%. Serum samples from patients with malignant melanoma positive for Linc01296 were selected according to the diagnostic threshold of 2.149 determined in this study. Then, the dye-based fluorescent quantitative kit of the present invention was used to carry out repeated experiments on the positive samples for 3 consecutive times, and the r...
Embodiment 3
[0088] Example 3 qRT-PCR detection of expression of Linc01296 in serum of patients with malignant melanoma before and after radical operation
[0089] 1. Experimental materials
[0090] 1. Serum collected from 76 patients with malignant melanoma who underwent radical resection before and 3 months after surgery.
[0091] 2. Dye-based Linc01296 qRT-PCR kit (the components are the same as above).
[0092] 2. Experimental method
[0093] 1. Total RNA Extraction from Serum Samples
[0094] The total RNA in the serum of healthy controls, skin benign moles and malignant melanoma patients was extracted according to the reagents and steps required by Tiange Biochemical Technology (Beijing) Co., Ltd. High Efficiency Blood Total RNA Extraction Kit (Product No. DP443). The specific steps are as mentioned above.
[0095] 2. Amplification of Linc01296: According to the reagents and steps required by the one-step reverse transcription-fluorescence quantitative kit (product number FP303) ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com